NPI: 1669788980 · SAN DIEGO, CA 92129 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 08/24/2010
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 08/24/2010 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,671 | $1.82M |
| 2019 | 13,355 | $619K |
| 2020 | 10,017 | $621K |
| 2021 | 12,686 | $634K |
| 2022 | 13,947 | $701K |
| 2023 | 10,960 | $870K |
| 2024 | 8,467 | $895K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 36,489 | 2,835 | $5.90M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 19,196 | 1,316 | $107K |
| A4657 | Syringe, with or without needle, each | 2,291 | 1,356 | $80K |
| J1756 | Injection, iron sucrose, 1 mg | 4,998 | 1,584 | $27K |
| J1270 | Injection, doxercalciferol, 1 mcg | 6,008 | 560 | $20K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,053 | 683 | $13K |
| 0250 | 4,104 | 344 | $13K | |
| 83550 | 566 | 533 | $2K | |
| 82728 | 642 | 612 | $1K | |
| 83970 | 683 | 655 | $944.58 | |
| 83540 | 700 | 666 | $388.97 | |
| 85041 | 1,290 | 1,223 | $148.79 | |
| 85048 | 1,289 | 1,222 | $105.83 | |
| 90662 | 55 | 50 | $74.41 | |
| 82746 | 214 | 204 | $35.57 | |
| 90674 | 16 | 16 | $32.04 | |
| 82108 | 91 | 87 | $21.68 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 155 | 110 | $16.09 |
| 85045 | 153 | 147 | $2.15 | |
| G0008 | Administration of influenza virus vaccine | 15 | 13 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 60 | 58 | $0.00 |
| 82607 | 35 | 35 | $0.00 |